Shares of Tissue Regenix Group plc (LON:TRX – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 60.24 ($0.73) and traded as low as GBX 57 ($0.69). Tissue Regenix Group shares last traded at GBX 57.03 ($0.69), with a volume of 4,648 shares.
Tissue Regenix Group Stock Performance
The firm has a market capitalization of £40.67 million, a PE ratio of -5,709.00 and a beta of 1.61. The company has a debt-to-equity ratio of 35.69, a quick ratio of 2.36 and a current ratio of 3.74. The business’s fifty day simple moving average is GBX 58.26 and its 200-day simple moving average is GBX 60.16.
Tissue Regenix Group Company Profile
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Featured Stories
- Five stocks we like better than Tissue Regenix Group
- 3 Small Caps With Big Return Potential
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Where to Find Earnings Call Transcripts
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- The Basics of Support and Resistance
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
